Forte: 'Hold' On Positive FB102 Vitiligo Treatment Data And argenx Acquisition For $2.2 Billion

Forte Biosciences is being acquired by Argenx for $2.2 billion [$77/share], capping near-term upside. Click here to read my ...
TMCnet

Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX

Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Forte Biosciences, Inc. (NasdaqCM: FBRX) to argenx SE (NasdaqGS: ARGX). Under the terms of the ...
Las Vegas Sun

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline

argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company, and Forte Biosciences, Inc. (Nasdaq: FBRX) today announced that the companies have entered into a definitive agreement under ...

Kia Forte

Get in-depth unbiased information on the Kia Forte from Consumer Reports including major redesigns, pricing and performance, and search local inventory ...

Argenx to buy Forte Biosciences for about $2.2 billion

July 27 (Reuters) - Belgian-Dutch immunology company argenx will buy Forte Biosciences to add experimental autoimmune drug FB102 to its portfolio, the company said on Monday. Argenx will pay $77 a ...

Italian fashion brand Forte_Forte opens new store in Paris' Marais area

CEO Paolo Chiesa mapped out the strategy for the Italian advanced contemporary label, which has accelerated its retail ...